Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07110207

Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Potentials

The FRONTAL-PEG study focuses on taste perception in frontotemporal lobar degeneration (FTLD). This neurodegenerative disease, characterised by progressive loss of nerve cells, is the second leading cause of dementia after Alzheimer's disease.

Patients with FTLD often experience olfactory disorders (= sense of smell) and eating disorders: increased appetite, increased food intake and excessive consumption of sugary foods and snacking. This often leads to excessive weight gain. These eating disorders are still poorly understood at present.

In this context, we hypothesise that an alteration in the gustatory pathway - i.e. the way in which the brain perceives taste - could contribute to the eating disorders frequently observed in frontotemporal dementia (FTD), particularly in the marked attraction to sweet foods. We therefore wish to objectively evaluate the taste response to a sweet solution (sucrose) in patients with FTLD, using taste evoked potentials (TEPs). Taste evoked potentials are a reliable and reproducible technique for assessing brain activity in response to taste stimulation. One of their advantages is that they are non-invasive.

This study will document, for the first time in this disease, the characteristics of cortical (brain) processing of taste information.

The FRONTAL-PEG study is an interventional, regional, single-centre study conducted at the Dijon University Hospital, in collaboration with the CMRR (Memory, Resources and Research Centre) and the CSGA (Centre for Taste and Food Sciences).

All investigations are carried out at the CSGA (building adjacent to the Dijon University Hospital), with the exception of blood tests, which are carried out at the Dijon University Hospital.

The total duration of participation in the study is one morning. No follow-up is planned at the end of the study.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Person who has given their free and informed consent
  • Person of legal age
  • Fasting > 2 hours before PEG measurement
  • Body Mass Index (BMI) < 30 kg/m² (according to medical record data)
  • DLFT: diagnostic criteria for established or probable DLFT

Exclusion criteria

  • Persons not affiliated with or not covered by a social security scheme
  • Persons subject to legal protection measures (guardianship, trusteeship)
  • Persons subject to judicial protection measures
  • Pregnant women, women in labour or breastfeeding women
  • MMSE score < 15 and/or MoCA score < 10
  • Known COVID-19 infection within 6 months prior to inclusion
  • Active smokers (> 4 cigarettes per day on a regular basis)
  • Subject with a pacemaker (contraindication for bioelectrical impedance analysis)
  • Subject with diabetes (type 1 or type 2)
  • Taking medication (during the study) that interferes with taste

Treatment and study plan

blood test

Biological

Metabolic measurements and measurements of hormones related to food intake

Interrogation of the subject

Other

Collection of socio-demographic data, medical and family history, medication

Cognitive Assessment

Other

MMSE and MoCA cognitive tests

Nutritional Assessment

Other

Anthropometric data (weight, height, BMI, waist circumference, hip circumference, android/gynoid ratio, triceps skinfold thickness, brachial circumference), bioelectrical impedance analysis (body fat percentage, lean body mass, body water percentage and bone mass in kg)

Taste tests

Other

Recording of PEGs in response to a sucrose solution (prepared beforehand)

Sucrose taste detection test

Other

Triangular test

Primary outcomes

  1. Average latency of taste evoked potentials

    Time frame: After a fasting period of at least two hours

Study contacts

Contact information is provided by the study sponsor or research team.

Agnès JACQUIN-PIQUES

CONTACT

[email protected]

03 80 29 59 02

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire Dijon

Other

Registry information

Acronym: FRONTAL-PEG

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Aug 7, 2025
Registry last updated
Aug 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.